Nutritional and Metabolic Diseases: News and Research on Nutritional and Metabolic Diseases

MeSH tree: C18

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...

page 3 from 40